Abstract:IntroductionA pivotal effect of lymphatic vessel (LV) function in joint homeostasis was identified in the tumor necrosis factor-transgenic (TNF-Tg) mouse model of rheumatoid arthritis (RA). Specifically, loss of LV contractions is associated with progressive synovitis and erosions. Furthermore, draining lymph node expansion is a biomarker of arthritic progression, and both macrophages and lymphatic endothelial cells express inducible nitric oxide synthase (iNOS), which disrupts LV contraction and transport of … Show more
“…After 28 days of therapy, the NO inhibitor did not significantly decrease DAS28 scores or synovitis scoring via ultrasound compared to placebo, while prednisone significantly reduced both outcome measures (43). Interestingly, the contraction frequency defect in murine TNF-transgenic end-stage arthritis can be recovered with both chemical iNOS inhibition and global genetic iNOS ablation, but has no effect on arthritis severity (15,16). The limited effectiveness of NO inhibitors in the treatment of RA may be due to the various roles NO plays in the bone and lymphatic microenvironments (16,44), in addition to our finding that RA patients do not have LV contraction deficits (Figure 3).…”
Section: Discussionmentioning
confidence: 61%
“…Interestingly, the contraction frequency defect in murine TNF-transgenic end-stage arthritis can be recovered with both chemical iNOS inhibition and global genetic iNOS ablation, but has no effect on arthritis severity (15,16). The limited effectiveness of NO inhibitors in the treatment of RA may be due to the various roles NO plays in the bone and lymphatic microenvironments (16,44), in addition to our finding that RA patients do not have LV contraction deficits (Figure 3). Our findings suggest that LV contraction frequency may not significantly contribute to lymphatic clearance of the web spaces, and thus therapeutic intervention targeting LV contraction frequency may not be efficacious in treating RA.…”
Section: Discussionmentioning
confidence: 61%
“…In the TNFtransgenic murine model of arthritis, no changes in contraction frequency were observed during the onset of disease, but during end-stage disease there was a complete cessation of contractions, with significantly diminished clearance, lymph velocity, and lymph pumping pressure (7)(8)(9)15). Interestingly, this contraction frequency defect can be recovered with both chemical inducible nitric oxide synthase (iNOS) inhibition and genetic iNOS ablation, but has no effect on arthritis severity (15,16). One potential explanation for our clinical finding is that there were fewer total functional vessels to carry the lymph fluid despite maintenance of contraction frequency, resulting in diminished clearance.…”
Section: Discussionmentioning
confidence: 99%
“…Lymphatic anatomy of the hands and forearm have been characterized previously, and we used these data as references (28)(29)(30)(31). ROIs were placed over the LVs, NIR/ICG signal intensity was measured over time, and boluses of dye flowing through the LVs, marked by peaks in signal intensity, were counted (by RDB and HMK) in order to generate contractions per minute, similar to previously described murine NIR methods (16). Contractions were quantified as both the sum and the average of all contractions on the basilic or cephalic bundle, as described in Supplementary Figures 1A-D (http://onlin e libr ary.wiley.com/doi/10.1002/art.41311/ abstract).…”
Section: Methodsmentioning
confidence: 99%
“…The lymphatic system provides homeostatic turnover of interstitial fluid and trafficking of immune cells to the closest lymph node (4,5). Multiple studies on murine RA models have demonstrated dramatic changes in both lymphatic vessel (LV) contractions and the joint-draining lymph node volume with disease progression (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17). During the early and middle phases of musculoskeletal inflammation, the joint-draining lymph node undergoes a rapid increase in volume to several fold greater than unaffected lymph nodes.…”
Objective
To assess differences between lymphatic function in the affected hands of rheumatoid arthritis (RA) patients with active synovitis and that of healthy controls, using indocyanine green (ICG) dye and near‐infrared (NIR) imaging.
Methods
NIR imaging of the hands of 8 patients with active RA and 13 healthy controls was performed following web space injection of 0.1 ml of 100 μM ICG. The percentage of ICG retention in the web spaces was determined by NIR imaging at baseline and at 7 days (±1 day) after the initial injections; image analysis provided contraction frequency. ICG+ lymphatic vessel (LV) length and branching architecture were assessed.
Results
Retention of ICG in RA hands was higher compared to controls (P < 0.01). The average contraction frequency of ICG+ LVs in RA patients and in controls did not differ (mean ± SD 0.53 ± 0.39 contractions/minute versus 0.51 ± 0.35 contractions/minute). Total ICG+ LV length in RA hands was lower compared to healthy controls (58.3 ± 15.0 cm versus 71.4 ± 16.1 cm; P < 0.001), concomitant with a decrease in the number of ICG+ basilic LVs in the hands of RA patients (P < 0.05).
Conclusion
Lymphatic drainage in the hands of RA patients with active disease was reduced compared to controls. This reduction was associated with a decrease in total length of ICG+ LVs on the dorsal surface of the hands, which continued to contract at a similar rate to that observed in controls. These findings provide a plausible mechanism for exacerbation of synovitis and joint damage, specifically the accumulation and retention of inflammatory cells and catabolic factors in RA joints due to impaired efferent lymphatic flow. NIR/ICG imaging of RA hands is feasible and warrants formal investigation as a primary outcome measure for arthritis disease severity and/or persistence in future clinical trials.
“…After 28 days of therapy, the NO inhibitor did not significantly decrease DAS28 scores or synovitis scoring via ultrasound compared to placebo, while prednisone significantly reduced both outcome measures (43). Interestingly, the contraction frequency defect in murine TNF-transgenic end-stage arthritis can be recovered with both chemical iNOS inhibition and global genetic iNOS ablation, but has no effect on arthritis severity (15,16). The limited effectiveness of NO inhibitors in the treatment of RA may be due to the various roles NO plays in the bone and lymphatic microenvironments (16,44), in addition to our finding that RA patients do not have LV contraction deficits (Figure 3).…”
Section: Discussionmentioning
confidence: 61%
“…Interestingly, the contraction frequency defect in murine TNF-transgenic end-stage arthritis can be recovered with both chemical iNOS inhibition and global genetic iNOS ablation, but has no effect on arthritis severity (15,16). The limited effectiveness of NO inhibitors in the treatment of RA may be due to the various roles NO plays in the bone and lymphatic microenvironments (16,44), in addition to our finding that RA patients do not have LV contraction deficits (Figure 3). Our findings suggest that LV contraction frequency may not significantly contribute to lymphatic clearance of the web spaces, and thus therapeutic intervention targeting LV contraction frequency may not be efficacious in treating RA.…”
Section: Discussionmentioning
confidence: 61%
“…In the TNFtransgenic murine model of arthritis, no changes in contraction frequency were observed during the onset of disease, but during end-stage disease there was a complete cessation of contractions, with significantly diminished clearance, lymph velocity, and lymph pumping pressure (7)(8)(9)15). Interestingly, this contraction frequency defect can be recovered with both chemical inducible nitric oxide synthase (iNOS) inhibition and genetic iNOS ablation, but has no effect on arthritis severity (15,16). One potential explanation for our clinical finding is that there were fewer total functional vessels to carry the lymph fluid despite maintenance of contraction frequency, resulting in diminished clearance.…”
Section: Discussionmentioning
confidence: 99%
“…Lymphatic anatomy of the hands and forearm have been characterized previously, and we used these data as references (28)(29)(30)(31). ROIs were placed over the LVs, NIR/ICG signal intensity was measured over time, and boluses of dye flowing through the LVs, marked by peaks in signal intensity, were counted (by RDB and HMK) in order to generate contractions per minute, similar to previously described murine NIR methods (16). Contractions were quantified as both the sum and the average of all contractions on the basilic or cephalic bundle, as described in Supplementary Figures 1A-D (http://onlin e libr ary.wiley.com/doi/10.1002/art.41311/ abstract).…”
Section: Methodsmentioning
confidence: 99%
“…The lymphatic system provides homeostatic turnover of interstitial fluid and trafficking of immune cells to the closest lymph node (4,5). Multiple studies on murine RA models have demonstrated dramatic changes in both lymphatic vessel (LV) contractions and the joint-draining lymph node volume with disease progression (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17). During the early and middle phases of musculoskeletal inflammation, the joint-draining lymph node undergoes a rapid increase in volume to several fold greater than unaffected lymph nodes.…”
Objective
To assess differences between lymphatic function in the affected hands of rheumatoid arthritis (RA) patients with active synovitis and that of healthy controls, using indocyanine green (ICG) dye and near‐infrared (NIR) imaging.
Methods
NIR imaging of the hands of 8 patients with active RA and 13 healthy controls was performed following web space injection of 0.1 ml of 100 μM ICG. The percentage of ICG retention in the web spaces was determined by NIR imaging at baseline and at 7 days (±1 day) after the initial injections; image analysis provided contraction frequency. ICG+ lymphatic vessel (LV) length and branching architecture were assessed.
Results
Retention of ICG in RA hands was higher compared to controls (P < 0.01). The average contraction frequency of ICG+ LVs in RA patients and in controls did not differ (mean ± SD 0.53 ± 0.39 contractions/minute versus 0.51 ± 0.35 contractions/minute). Total ICG+ LV length in RA hands was lower compared to healthy controls (58.3 ± 15.0 cm versus 71.4 ± 16.1 cm; P < 0.001), concomitant with a decrease in the number of ICG+ basilic LVs in the hands of RA patients (P < 0.05).
Conclusion
Lymphatic drainage in the hands of RA patients with active disease was reduced compared to controls. This reduction was associated with a decrease in total length of ICG+ LVs on the dorsal surface of the hands, which continued to contract at a similar rate to that observed in controls. These findings provide a plausible mechanism for exacerbation of synovitis and joint damage, specifically the accumulation and retention of inflammatory cells and catabolic factors in RA joints due to impaired efferent lymphatic flow. NIR/ICG imaging of RA hands is feasible and warrants formal investigation as a primary outcome measure for arthritis disease severity and/or persistence in future clinical trials.
The risk of osteoporosis is increased in rheumatoid arthritis (RA). Anti-tumor necrosis factor (TNF) therapy has markedly improved the outcomes of RA patients but does not improve osteoporosis in some reports. This could be a combined result of disease severity and other therapeutic agents, such as glucocorticoids that accelerate osteoporosis progression. We evaluated the effects of anti-TNF therapy on osteoporosis in an animal model of RA and explored the possible mechanisms involved. Six-week-old TNF transgenic (TNF-Tg) mice with early stage erosive arthritis were treated with TNF antibody (Ab) or control immunoglobulin (IgG) weekly for 4 weeks. We found that TNF Ab completely blocked the development of erosive arthritis in TNF-Tg mice, but only slightly increased vertebral bone mass, associated with reduction in parameters of both bone resorption and formation. Similarly, TNF Ab slightly increased trabecular bone mass in tibias of 8-month-old TNF-Tg mice with advanced erosive arthritis. Interestingly, TNFα increased osteoblast differentiation from mouse bone marrow stromal cells (BMSCs) containing large number of macrophages but not from pure mesenchymal progenitor cells (MPCs). TNFα-polarized macrophages (TPMs) did not express iNos and Arginase 1, typical markers of inflammatory and resident macrophages. Interestingly, TPMs stimulated osteoblast differentiation, unlike resident and inflammatory macrophages polarized by IL-4 and interferon-λ, respectively. RNA-seq analysis indicated that TPMs produced several anabolic factors, including Jagged1 and insulin like 6 (INSL6). Importantly, inhibition of either Jagged1 or INSL6 blocked TNFα-induced osteoblast differentiation. Furthermore, INSL6 Ab significantly decreased the expansion of TNF-induced MPCs in BMSCs, and anti-TNF Ab reduced INSL6 expression by macrophages in vitro and in TNF-Tg mice in vivo. We conclude that TPMs produce INSL6 to stimulate bone formation and anti-TNF Ab blocks not only enhanced bone resorption but also the anabolic effect of TPMs on bone, limiting its effect to increase bone mass in this model of RA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.